Insulet



Ebitda تغيير تاريخ
Abbott USD 2.18B 486M 2025-03
Align Technology USD 137.61M 77.61M 2025-03
AtriCure USD -870000 8.83M 2025-03
Avanos Medical USD 28.6M 2M 2024-12
Baxter International USD 576M 116M 2024-12
Becton, Dickinson and Co. USD 1.39B 138M 2025-03
Boston Scientific USD 1.36B 16M 2025-03
Cardinal Health USD 938M 180M 2025-03
Cooper Companies USD 243.8M 45.6M 2025-01
Dexcom USD 193.7M 111.6M 2025-03
Edwards Lifesciences USD 411.3M 15.3M 2025-03
Eli Lilly USD 4.16B 2B 2025-03
Globus Medical USD 145.33M 29.19M 2024-12
ICU Medical USD 100.77M 19.72M 2024-12
Insulet USD 130.8M 21.4M 2024-12
Integra LifeSciences USD 104.98M 43.09M 2024-12
J&J USD 7.88B 1.76B 2025-03
Masimo USD -25600000 79.7M 2024-12
Medtronic USD 2.44B 134M 2025-01
Merit Medical Systems USD 73.31M 3.35M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Solventum Corp 483M 75M 2024-12
Stryker USD 1.42B 519M 2025-03
Tandem Diabetes Care USD -30183000 33.85M 2025-03
Teleflex USD 194.82M 17.78M 2025-03
West Pharmaceutical Services USD 164.8M 43.8M 2025-03
Zimmer Biomet Holdings USD 709.4M 138.6M 2024-12



Insulet - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.